We identified several DEGs involved in the cell cycle, including CDK1, CHEK1, CDC25C, BUB1, CDC20, and TTK, which not only are related to breast cancer patient survival but also have existing targeted drugs. This evidence concerns the gene CDC25C and breast carcinoma.